Science in the Senate

New Majority Leader's influence on US science policy and funding hard to predict.

Written byCatherine Zandonella
| 5 min read

Register for free to listen to this article
Listen with Speechify
0:00
5:00
Share

He has piloted planes into African war zones, sweated through seven marathon races, and performed more than 250 heart-and-lung transplant surgeries. But moving science-related legislation through Congress may be the greatest challenge the new Senate Majority Leader William H. Frist has ever faced. The Republican senator from Tennessee officially took the mantle of Majority Leader last week, replacing Senator Trent Lott, who was ousted from the position in late 2002.

How the Harvard-trained transplant surgeon will act on science policy and funding issues is difficult to predict. He has long been a champion of science funding, and likely understands the technical side of issues dear to scientists' hearts better than most senators. However, his ascension to leadership of the Senate has been greeted with tempered enthusiasm from the science community.

Frist's clear stance in favor of banning "therapeutic" cloning, his role in inserting language into the Homeland Security Act barring ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to more than 35 years of archives, as well as TS Digest, digital editions of The Scientist, feature stories, and much more!
Already a member? Login Here

Related Topics

Meet the Author

Share
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter Logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies